These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31997117)

  • 1. Nursing Home Residents' Thoughts on Discussing Deprescribing of Preventive Medications.
    Thompson W; Jacobsen IT; Jarbøl DE; Haastrup P; Nielsen JB; Lundby C
    Drugs Aging; 2020 Mar; 37(3):187-192. PubMed ID: 31997117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents.
    Lundby C; Glans P; Simonsen T; Søndergaard J; Ryg J; Lauridsen HH; Pottegård A
    J Am Geriatr Soc; 2021 Jun; 69(6):1508-1518. PubMed ID: 33598916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study.
    Kua CH; Mak VS; Lee SWH
    BMJ Open; 2019 Oct; 9(10):e030106. PubMed ID: 31604786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I simply don't know, because I don't know which drugs I get": Perspectives on deprescribing among older adults with limited life expectancy and their relatives.
    Graabaek T; Lundby C; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):115-127. PubMed ID: 32770703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing medication use in nursing home residents with life-limiting disease.
    Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
    Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors.
    Onder G; Vetrano DL; Villani ER; Carfì A; Lo Monaco MR; Cipriani MC; Manes Gravina E; Denkinger M; Pagano F; van der Roest HG; Bernabei R
    J Am Med Dir Assoc; 2019 Sep; 20(9):1116-1120. PubMed ID: 30853425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic medication deprescribing in residential aged care facilities: An exploratory study of the knowledge and attitudes of family members of residents with dementia.
    Lai R; Withiel TD; Angelone M; Redpath C; O'Connor DW; Plakiotis C
    Australas J Ageing; 2022 Dec; 41(4):e356-e363. PubMed ID: 35166431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an interprofessional deprescribing intervention in Swiss nursing homes: the Individual Deprescribing Intervention (IDeI) randomised controlled trial.
    Cateau D; Ballabeni P; Niquille A
    BMC Geriatr; 2021 Nov; 21(1):655. PubMed ID: 34798826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
    Niznik JD; Aspinall SL; Hanson LC; Gilliam MA; Li X; Kelley CJ; Thorpe CT
    Osteoporos Int; 2022 Feb; 33(2):379-390. PubMed ID: 34480586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. They know!-Do they? A qualitative study of residents and relatives views on advance care planning, end-of-life care, and decision-making in nursing homes.
    Bollig G; Gjengedal E; Rosland JH
    Palliat Med; 2016 May; 30(5):456-70. PubMed ID: 26396227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives of residential aged care facilities' staff on the identification and recording of residents' medication-related goals of care.
    Sawan M; Kouladjian O'Donnell L; Hilmer SN
    Australas J Ageing; 2020 Mar; 39(1):e134-e144. PubMed ID: 31397539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential for deprescribing in care home residents with Type 2 diabetes.
    Andreassen LM; Kjome RL; Sølvik UØ; Houghton J; Desborough JA
    Int J Clin Pharm; 2016 Aug; 38(4):977-84. PubMed ID: 27241345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial.
    Balsom C; Pittman N; King R; Kelly D
    Int J Clin Pharm; 2020 Aug; 42(4):1153-1167. PubMed ID: 32494991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients.
    Thompson W; Nissen M; Haastrup P; Le JV; Lundby C; Nielsen JB; Jarbøl DE
    BMC Fam Pract; 2020 Aug; 21(1):160. PubMed ID: 32770959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.